New Business Market Research: A Complete Guide to Longlist Development and Market Viability Assessment
The Core Challenges Facing New Business, CVC, and Corporate Development Teams
In 2026, with internal and external uncertainty at an all-time high, the pressure on New Business Development teams, CVCs, and Corporate Development professionals has never been greater.
Despite reviewing countless reports and IR materials every day, practitioners consistently find themselves wrestling with the same five fundamental questions:
Practitioners must first address the fundamental question: "Will this business generate immediate or near-term returns?" This is followed by strategic considerations regarding whether the opportunity aligns with the direction their core business needs to move.
From there, the questions become more analytical: "What objective criteria can we use to assess true market viability — beyond the rosy projections?" And then: "Can our existing technical capabilities extend into adjacent industries?"
Finally: "Where are our competitors acquiring and investing right now?"
Answering these five questions clearly is the prerequisite for any successful New Business Development initiative.
A Structured Approach to Market Viability Assessment
When evaluating New Business Development opportunities or M&A targets, a multidimensional view of the market matters far more than any single metric. Objectively assessing market attractiveness requires analysis across three core dimensions.
1. The Three Core Metrics of Market Attractiveness
Dimension | Key Analysis | Purpose |
|---|---|---|
Market Size | Total revenue pool and addressable market (TAM (Total Addressable Market) / SAM (Serviceable Addressable Market) / SOM (Serviceable Obtainable Market)) | Assess revenue potential and growth ceiling |
Growth Rate | CAGR (Compound Annual Growth Rate) and market momentum | Forecast future cash flows and identify stagnation risk |
Competitive Intensity | Key player market share and barriers to entry | Gauge realistic margin potential and profitability |
2. Understanding the Trade-Offs Between Metrics
A critical point in market analysis is that these three dimensions exist in complex tension with one another.
The red ocean trap: Large, high-growth markets are attractive — but they inevitably attract intense competition, which compresses margins.
The niche market ceiling: Markets with low competition and easy entry are often too small or already stagnating.
Effective Deal sourcing, therefore, is not about finding a market that scores highest on all three dimensions simultaneously. It is about identifying the optimal balance point — where competitive intensity is manageable, and meaningful growth potential and scale are both present.
3. Mapping Internal Capabilities: Technology and Industry Fit
Once the external market analysis is complete, it must be integrated with an honest assessment of your organization's internal capabilities.
If the three core metrics answer "Is this objectively a good market?", capability mapping answers "Do we have a realistic chance of winning if we enter?"
No matter how strong the market indicators are, if there is no meaningful connection to your company's core technology or customer base, the investment risks becoming a purely financial play — or failing at the execution stage.
The winning strategy lies in cross-referencing external market attractiveness with internal technological fit.
The essence of M&A and New Business Development review is identifying a point of clear competitive advantage — where your company's unique assets can generate Synergy, even in a market that may look ordinary to everyone else.
Case Study: LG Chem's Expansion into Semiconductor Specialty Materials
LG Chem (a South Korean petrochemical and advanced materials conglomerate) provides a strong example of this structured approach to market viability assessment.
Facing headwinds in petrochemicals and slowing growth in the battery market, LG Chem identified semiconductor specialty materials as a high-potential alternative — a sector poised for growth in the AI era.
The company recognized that while Japanese firms dominate the space and entry barriers (competitive intensity) are high, securing a position in the Value Chain would deliver gross margins of 30–50%.
This reflects a deliberate strategy: rather than pursuing an easy-entry niche, LG Chem chose a high-difficulty market with proven scale and profitability — seeking the optimal balance point within the trade-off framework.
LG Chem confirmed technological adjacency by identifying that its existing petrochemical process expertise could be applied to wafer planarization and circuit process materials. The company also drew on its track record of successfully catching up to market leaders in the display materials business.
In short, this is a textbook example of structured market viability assessment — cross-referencing market attractiveness (growth and profitability) with internal execution capability (technological fit) to conclude that a high-barrier market is still winnable.
The 6-Step Longlist Development Process for New Business and M&A
Rather than searching for acquisition targets without a clear framework, running candidates through a systematic funnel minimizes the Risk of poor targeting. The six-step process for successful Deal sourcing is as follows:
Value Chain Decomposition: Deconstruct the industry Value Chain into primary and support activities to define critical success factors (CSFs) and required capabilities at each stage. Use this as the basis for a comparative analysis of your capabilities versus competitors — identifying relative strengths and weaknesses — and draw final strategic implications.
Build an Initial Universe of 30–100 Companies: Cast a wide net across all players within the defined segment. Do not filter by revenue size or brand recognition at this stage — include startups through mid-sized enterprises to build a comprehensive pool of 30–100 preliminary candidates with no gaps.
Filter by Technology, Customer, and Revenue Model Fit: Apply your company's strategic criteria to conduct a first-pass screening. Eliminate companies that do not meet the bar on technology differentiation, customer segment alignment, and business model scalability — narrowing the field to a focused set for deeper review.
Expert Interview-Based Initial Validation: Conduct Expert Interviews with current and former industry practitioners and technical specialists to surface the "real reputation" that financial statements and company websites never reveal. Identify qualitative Risks — actual technology implementation maturity, competitive sales effectiveness, internal organizational issues — and filter out companies that look good on paper but lack substance.
Shortlist Conversion Criteria: From the validated candidates, select the 3–5 companies with the highest acquisition potential and Synergy value. At this stage, weight Deal feasibility factors heavily — including the owner's willingness to sell and valuation expectations — not just market attractiveness.
Due Diligence Preparation Materials: Prepare the groundwork for formal engagement and Due Diligence (DD) on Shortlisted companies. Develop estimated acquisition price ranges, key management interview question sets, and legal/financial Risk checklists — establishing the foundation for transitioning into the live Deal process.
Three Common Mistakes Made by New Business Development Practitioners
Even after building a solid Longlist, teams frequently encounter unexpected Risks when moving into actual investment or commercialization. These failures typically stem from structural errors — misreading the nature of available data or setting too narrow a scope for validation. The three most common judgment errors in New Business Development are:
First: Over-Reliance on Lagging Indicators from Research Reports
Research reports are useful for understanding macro-level industry trends, but they have an inherent limitation: data lag means they do not reflect current market conditions in real time.
A sector may show strong growth rates on paper while, in practice, the market has already become oversaturated — with margins deteriorating and entry barriers firmly in place.
Use quantitative data from reports as a reference point, but recognize that it does not represent the current competitive position of individual companies or the live Deal environment.
Second: Skipping Multi-Dimensional Validation Across Technology, Market, and Regulatory Dimensions
This is the error of focusing on a technology's "innovation" while overlooking its "manufacturability" and "regulatory durability." In deep tech and biotech in particular, the path from laboratory-stage technology to commercial-scale deployment often takes far longer and costs far more than anticipated.
Business models built on temporary regulatory exemptions — such as regulatory sandboxes — face the Risk of legal challenges that threaten operational continuity. Separate legal and technical assessments of technology maturity and the regulatory environment must precede any investment decision.
Third: Skipping Cross-Validation with Practitioners and Industry Experts
There is tacit knowledge on the ground that financial data and top management's strategic judgment simply cannot capture.
Current and former practitioners and engineers in a given industry hold qualitative intelligence that no document contains: the actual difficulty of implementing a technology, how competitors sell, and the organizational culture of a target company.
Making decisions through a purely Top-Down approach — without validating these insider perspectives — significantly increases the probability that hidden Risks will materialize during Post-Merger Integration (PMI) or actual operations.
How to Use AI ENS Brainconnect AI to Validate Your Longlist
To address the "research report trap" and the absence of on-the-ground validation described above, strategy and investment professionals at a growing number of companies are turning to Brainconnect AI as their primary tool for Longlist validation.
The core reason is simple: Short Interviews with industry experts surface real-world intelligence that desk research cannot.
To deliver this, Brainconnect AI maintains a validated expert network spanning 47 countries — covering not only prominent academics and C-suite executives, but also manager-level practitioners actively working in the field.
Above all, Brainconnect AI delivers cost-efficient access through AI-powered matching and a transparent pricing model.
Dramatically more efficient than traditional consulting: Instead of heavy consulting engagements that carry significant fees and take two to three weeks to mobilize, AI-powered matching connects you with the right expert immediately.
50%+ cost savings versus other global ENS platforms: Brainconnect AI's industry-leading 20-minute billing increment dramatically reduces budget pressure — even when validating a large number of Longlist candidates.
Complete pre-validation in the time it takes to have a coffee: With no complex contracts required, a single 20-minute conversation is enough to determine whether a market represents a genuine opportunity or a poisoned chalice — making it one of the most effective Risk management tools available for minimizing the cost of failure.
Don't let an overwhelming Longlist stall your progress. Leverage Brainconnect AI to gain direct access to on-the-ground experts today. A 20-minute conversation — just a few clicks away — may be the most reliable insurance policy against a costly investment mistake.
Need deeper expert insight on capital and financial markets?
Access live, actionable intelligence from industry experts through Brainconnect AI.
Gain decisive insights through Expert Interviews — and uncover the Risks hiding beneath the surface.